Doubling down on efficacy: Exploring the potential of dual-payload ADCs
Chemotherapy has been our main weapon against late-stage cancers for decades, bringing with it wide-ranging side effects caused by the…
Chemotherapy has been our main weapon against late-stage cancers for decades, bringing with it wide-ranging side effects caused by the…
Dr. Scott Jones has spent more than 35 years advancing assay development and currently leads BioBridge Global’s R&D department. His…
Disrupted bile flow, or cholestasis, is a key feature of various chronic liver diseases such as primary biliary cholangitis (PBC)…
In a parenteral packaging world often dominated by discussion of vials, stoppers, and pre-filled syringes, flip caps rarely take centre…
This article explores the typical fill-finish process, the potential impact on unstable drug products, and best practices to protect these…
For decades, intravenous (IV) infusions in clinical settings were the standard for therapies such as monoclonal antibodies. Today, advances in…
Dr. Zamilpa is the Executive Director of Biomanufacturing and Collaborative Programs at BBG Advanced Therapies, a subsidiary of BioBridge Global…
Sharp Services, a leader in pharmaceutical packaging, clinical trial services and sterile manufacturing has announced a $100 million investment across its…
Regulations are the cornerstone of the pharmaceutical industry, with parenteral packaging often an area of scrutiny due to its importance…
Lyophilization is a vital tool to maintain product quality, extend shelf life, and protect delicate compounds. Many parenteral formulations and…